CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 74,256 enrolled
Drug / intervention
Chlorhexidine bath and nasal mupirocindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00980980
NCT00980980N/ACompleted

Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal

Harvard Pilgrim Health Care·interventional·Posted Sep 21, 2009·Updated May 2, 2017

In Brief

A clinical study evaluating Chlorhexidine bath and nasal mupirocin for Methicillin-resistant Staphylococcus Aureus. Completed, enrolled 74,256 participants across 42 sites.

Detailed Summary

The Randomized Evaluation of Decolonization versus Universal Clearance to Eliminate MRSA (REDUCE MRSA) Trial is a cluster randomized trial of the comparative effectiveness of three strategies to prevent methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units. The three strategies to be evaluated are: * screening on admission followed by isolation of MRSA+ patients * screening on admission followed by isolation and decolonization of MRSA+ patients * universal decolonization on admission with no screening. The decolonization regimen involves bathing with chlorhexidine plus intra-nasal application of mupirocin. The main outcome will be MRSA+ clinical cultures. The study is a partnership between the CDC, the CDC Prevention Epicenters, and the Hospital Corporation of America.

Study Details

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 21, 2009
Enrollment StartSep 1, 2009
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 16.8 years ago

Interventions

Chlorhexidine bath and nasal mupirocindrug

The intervention / decolonization regimen will consist of the most commonly used topical regimen in the US - a combination of daily baths with 2% chlorhexidine cloths , plus 5 days of topical intranasal mupirocin ointment (bilateral nares, twice daily)